Maarten Jan Suttorp

Showing 1-17 of 17 articles

Coronary interventions

Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial

Teeuwen K, Spoormans E, Bennett J, Dubois C, Desmet W, Ughi G, Belmans A, Kelder J, Tijssen J, Agostoni P, Suttorp MJ, Adrianssens T

August 4, 2017 | 10.4244/EIJ-D-17-00261

Coronary interventions

Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials

Wijns W, Suttorp MJ, Zagozdzon L, Morice M, McClean D, Stella P, Donohoe D, Knape C, Ormiston J

June 20, 2016 | 10.4244/EIJY15M09_14

Initial experience with therapeutic geometric modification of the carotid bulb for true resistant hypertension

Habib N, Mahmoodi BK, Bos WJ, Tromp SC, Suttorp MJ, Bates MC, Van der Heyden J

May 19, 2015 | 10.4244/EIJV11I1A20

Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions

Teeuwen K, Van den Branden B, Koolen J, van der Schaaf R, Henriques J, Thijssen J, Kelder J, Vermeersch P, Rensing B, Suttorp MJ

March 20, 2015 | 10.4244/EIJY14M08_07

Percutaneous reclosure of a patent foramen ovale after bioabsorbable device implantation

Snijder R, Post M, Suttorp MJ

November 20, 2014 | 10.4244/EIJV10I7A146

Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions

Van den Branden B, Teeuwen K, Koolen J, van der Schaaf R, Henriques J, Thijssen J, Kelder J, Vermeersch P, Rensing B, Suttorp MJ

November 29, 2013 | 10.4244/EIJV9I7A138

Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II)

Teeuwen K, Van den Branden B, Rahel B, Laarman G, Thijssen J, Kelder J, Slagboom T, ten Berg J, Suttorp MJ

June 28, 2013 | 10.4244/EIJV9I2A36

Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study)

Van den Branden B, Rahel B, Laarman G, Slagboom T, Kelder J, ten Berg J, Suttorp MJ

February 21, 2012 | 10.4244/EIJV7I10A190

Comparison of outcome after patent foramen ovale closure in older versus younger patients

Luermans J, Budts W, ten Berg J, Plokker H, Suttorp MJ, Post M

June 30, 2011 | 10.4244/EIJV7I2A35

CT measurement of changes in cerebral perfusion in patients with asymptomatic carotid artery stenosis undergoing carotid stenting prior to cardiac surgery: "proof of principle"

Van der Heyden J, Waaijer A, Van ES W, van Neerven D, Sonker U, Suttorp MJ, Bal E, Prokop M

April 20, 2011

Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study

Fajadet J, Wijns W, Laarman GJ, Kuck K, Ormiston J, Baldus S, Hauptmann K-E, Suttorp MJ, Drzewiecki J, Pieper M, Schultheiss H-P, Mauri L

November 15, 2010

Long-term outcome of percutaneous closure of secundum-type atrial septal defects in adults

Luermans J, Post M, ten Berg J, Plokker H, Suttorp MJ

November 15, 2010

The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: comparison of mid-term efficacy and safety

Van den Branden B, Luermans J, Post M, Plokker H, ten Berg J, Suttorp MJ

September 30, 2010

Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study

Dirksen M, Vink M, Suttorp MJ, Thijssen J, Patterson M, Slagboom T, Kiemeneij F, Laarman GJ

May 13, 2008

A novel ultra-thin bare metal stent (BMS): results from a worldwide registry

Blanchard D, Danzi G, Urban P, Moseri M, Juergens C, Guyon P, Nowak B, Tresukosol D, Suttorp MJ, Farshid A, Kornowski R, Garcia E, Yeend R, Nagai H, Paunovic D

August 20, 2007

Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry

Schultheiss H-P, Grube E, Kuck K, Suttorp MJ, Heuer H, Bonnier H, Popma J, Kuntz R, Fajadet J, Wijns W

May 22, 2007

One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.

Macaya C, Garcia-Garcia H, Colombo A, Morice M, Legrand V, Kuck K, Sheiban I, Suttorp MJ, Carrié D, Vrolix M, Wittebols K, Stoll H, Donohoe D, Bressers M, Serruys P

May 20, 2006

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers